Rhythm Pharmaceuticals
RYTM
#2970
Rank
HK$40.55 B
Marketcap
HK$593.88
Share price
-7.42%
Change (1 day)
42.78%
Change (1 year)

Revenue for Rhythm Pharmaceuticals (RYTM)

Revenue in 2025 (TTM): HK$1.47 Billion

According to Rhythm Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is HK$1.48 Billion. an increase over the revenue in the year 2024 that were of HK$1.01 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Rhythm Pharmaceuticals from 2017 to 2025

Annual revenue

Year Revenue Change
2025 HK$1.47 B46.15%
2024 HK$1.01 B67.06%
2023 HK$0.60 B227.42%
2022 HK$0.18 B650.97%
2021 HK$24.59 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA